![Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling]()
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic ProfilingLe, Xiuning; Freed, Jason A.; VanderLaan, Paul A.; Huberman, Mark S.; Rangachari, Deepa; Jorge, Susan E.; Lucena-Araujo, Antonio R.; Kobayashi, Susumu S.; Balasubramanian, Sohail; He, Jie; Chudnovsky, Yakov; Miller, Vincent A.; Ali, Siraj M.; Costa, Daniel B. · Clinical Lung Cancer · 2015